… the prognostic factors in metastatic colorectal cancer (mCRC) patients treated with cetuximab
and establish a prognostic … ; both KRAS and NRAS genes were wild ⁃ type; and at least 2 …

… adjuvant treatment of metastatic colon cancer, it … RAS wild-type colon cancer, and
chemo-therapy plus bevacizumab is the first-line treatment option for right RAS wild-type colon …

… of stage Ⅳ CRC patients after receiving integrated … prognosis of patients with mCRC is
controversial, in recent years, the results of international clinical trials showed that the prognosis …

… right-side colon, non-chemotherapy, RAS mutation, and low differentiation were independent
prognostic factors for poor prognosis of … with RAS wild-type metastatic colorectal cancer: …

… stretches from the right side of the superior mesenteric artery (… features and prognosis are
investigated in patients with CAC … positive predictive value (PPV), negative predictive value (…

… Prognostic and predictive value of primary tumour side in patients with RAS wild-type
metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six …

… of targeted drugs, the predicting of the efficacy and the evaluation of the prognosis. This paper
… to anti-EGFR mon-oclonal antibodies in metastatic colorectal cancer[J]. Journal of Modern …

… Leftsided primary tumors are associated with favorable prognosis in patients with KRAS
codon 12/13 wild-type metastatic colorectal cancer treated with cetuximab plus chemotherapy: …

… (FIRE⁃3):A post⁃hoc analysis of tumour dynamics in the final RAS wild ⁃ type subgroup
of this randomised open⁃label phase 3 trial[J]. Lancet Oncol,2016, 17(10):1426-1434. …

… as predictor of outcome in metastatic colorectal cancer patients … Wild⁃type KRAS and
BRAF could predict response to … Prognostic value of KRAS and BRAF mutations in curatively …